279 filings
Page 5 of 14
8-K
uxs84fl t2bc3oy
23 Feb 21
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
6:50am
8-K
r9ch8 mypyksy66
23 Dec 20
Termination of a Material Definitive Agreement
4:17pm
8-K
z6ne89
6 Nov 20
Epizyme Reports Business Progress and Third Quarter 2020 Financial Results
6:47am
8-K
e9agsv7s zfh2vb2foe3
4 Aug 20
Epizyme Reports Business Progress and Second Quarter 2020 Financial Results
6:52am
8-K
rj4n p4qt
3 Jun 20
Submission of Matters to a Vote of Security Holders
7:52am
8-K
3w0laakk8p7sk x9
4 May 20
Epizyme Reports Business Progress and First Quarter 2020 Financial Results
6:42am
DEFA14A
pkw5oqz6t
17 Apr 20
Additional proxy soliciting materials
2:05pm
PRE 14A
fku36 9zoc5enc
6 Apr 20
Preliminary proxy
9:46pm
8-K
u38r8w9gnf3hp4laeqd
3 Apr 20
Departure of Directors or Certain Officers
4:05pm
S-8
1ypf7trldfa 4h5p
27 Feb 20
Registration of securities for employees
12:00am
8-K
xvmghd5hwounoriv8zki
24 Feb 20
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
6:41am
SEC STAFF
uejv52
18 Feb 20
SEC staff action: Order
12:00am
SEC STAFF
ltm9ka
6 Feb 20
SEC staff action: Order
12:00am
8-K
t28xd1p
6 Jan 20
Epizyme Announces Exercise of $50 Million Option with Royalty Pharma and Highlights Key 2020 Initiatives to Build Long-Term Value
6:38am
8-K
uozj4vrclcver
4 Nov 19
Entry into a Material Definitive Agreement
7:11am